GE HealthCare Events Center

Pixxoscan™ (gadobutrol)

Request info

Pixxoscan™ (gadobutrol)

Introducing Pixxoscan (Gadobutrol), our macrocyclic, non-ionic gadolinium-based contrast agent (GBCA). The launch expands our portfolio of Magnetic Resonance Imaging (MRI) contrast agents, with two leading macrocyclic molecules - Clariscan™ (gadoteric acid) and now Pixxoscan (gadobutrol).
Pixxoscan is authorised in Austria, Norway, Spain and France (as Pixcyclic) and is not available in all of Europe. In the UK, Pixxoscan is known as Gadobutrol.

For full prescribing information on Gadobutrol in the UK, click here.
For full prescribing information on Clariscan in the UK click here

Adverse events should be reported.
Reporting forms and information can be found at: yellowcard.mhra.gov.uk
Adverse events should also be reported to GE HealthCare at: gpv.drugsafety@ge.com

ACKNOWLEDGEMENTS

GE HealthCare Events Center

Product availability

Not all products and solutions, shown on the GE HealthCare Events Center, may be available in your country. Please contact a GE HealthCare representative to confirm availability.

Information We Collect

We want to be transparent about the data we and our partners collect and how we use it, so you can best exercise control over your personal data. For more information, please see our Privacy Policy.

We use the following partners to better improve your overall web browsing experience. They use cookies and other mechanisms to connect you with your social networks and tailor advertising to better match your interests. You can elect to opt-out of this information collection by unticking the boxes below.